Clinical Trial Update: Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the combination of fulvestrant and bevacizumab in metastatic breast cancer. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Faslodex (fulvestrant)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04